References
- EnewoldLZhuKRonERising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980–2005Cancer Epidemiology Biomarkers & Prevention2009183784791
- VergaminiLBFrazierALAbrantesFLRibeiroKBRodriguez-GalindoCIncrease in the incidence of differentiated thyroid carcinoma in children, adolescents, and young adults: a population-based studyJ Pediatr201416461481148524630354
- LarijaniBShirzadMMohagheghiMAEpidemiologic analysis of the Tehran cancer institute data system registry (TCIDSR)Asian Pac J Cancer Prev200451363915075002
- HaghpanahVSoliemanpourBHeshmatREndocrine cancer in Iran: based on cancer registry systemIndian J Cancer20064328016790945
- MoonWJBaekJHJungSLUltrasonography and the ultrasound-based management of thyroid nodules: consensus statement and recommendationsKorean J Radiol201112111421228935
- LarijaniBMohagheghiMABastanhaghMHPrimary thyroid malignancies in Tehran, IranMed Princ Pract200514639640016220012
- CooperDSDohertyGMHaugenBRRevised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association (ATA) guidelines taskforce on thyroid nodules and differentiated thyroid cancerThyroid200919111167121419860577
- CibasESAliSZNCI Thyroid FNA State of the Science Conference. The Bethesda system for reporting thyroid cytopathologyAm J Clin Pathol2009132565866519846805
- PaciniFSchlumbergerMDralleHEuropean consensus for the management of patients with differentiated thyroid carcinoma of the follicular epitheliumEur J Endocrinol2006154678780316728537
- HaghpanahVShooshtarizadehPHeshmatRLarijaniBTavangarSMImmunohistochemical analysis of survivin expression in thyroid follicular adenoma and carcinomaAppl Immunohistochem Mol Morphol200614442242517122639
- SaniiSSaffarHTabrizHMQorbaniMHaghpanahVTavangarSMExpression of matrix metalloproteinase-2, but not caspase-3, facilitates distinction between benign and malignant thyroid follicular neoplasmsAsian Pac J Cancer Prev20121352175217822901190
- ProiettiABorrelliNGianniniRMolecular characterization of 54 cases of false-negative fine-needle aspiration among 1347 papillary thyroid carcinomasCancer Cytopathol20141221075175924913568
- Haddadi-NezhadSLarijaniBTavangarSMNouraeiSMComparison of fine-needle-nonaspiration with fine-needle-aspiration technique in the cytologic studies of thyroid nodulesEndocr Pathol200314436937414739493
- KhatamiFLarijaniBTavangarSMCirculating Tumor BRAF Mutation and Personalized Thyroid Cancer TreatmentAsian Pac J Cancer Prev201718229328345323
- KhatamiFTavangarSMLiquid biopsy in thyroid cancer: new insightInt J Hematol Oncol Stem Cell Res2018123234247
- TavangarSMMonajemzadehMLarijaniBHaghpanahVImmunohistochemical study of oestrogen receptors in 351 human thyroid glandsSingapore Med J200748874474717657383
- Mohammadi-AslJLarijaniBKhorgamiZQualitative and quantitative promoter hypermethylation patterns of the P16, TSHR, RASSF1A and RARβ2 genes in papillary thyroid carcinomaMed Oncol20112841123112820535589
- KildegaardHFBaycin-HizalDLewisNEBetenbaughMJThe emerging CHO systems biology era: harnessing the “omics revolution for biotechnologyCurr Opin Biotechnol20132461102110723523260
- SarmadiSIzadi-MoodNSotoudehKTavangarSMExpressionAPAltered PTEN expression; a diagnostic marker for differentiating normal, hyperplastic and neoplastic endometriumDiagn Pathol2009414119930726
- GilanyKMinai-TehraniAAminiMAgharezaeeNArjmandBThe challenge of human spermatozoa proteome: a systematic reviewJ Reprod Infertil201718326729062791
- JohnsonCHIvanisevicJSiuzdakGMetabolomics: beyond biomarkers and towards mechanismsNat Rev Mol Cell Biol201617745145926979502
- GilanyKJafarzadehNMani-VarnosfaderaniAMetabolic fingerprinting of seminal plasma from non-obstructive Azoospermia patients: positive versus negative sperm retrievalJ Reprod Infertil201819210911430009145
- AgharezaeeNMarzbaniRRezadoostHKoukhalooSZArjmandBGilanyKMetabolomics: a bird’s eye view of infertile menTehran University Medical Journal20187512860868
- CollinsRRJPatelKPutnamWCKapurPRakhejaDOncometabolites: a new paradigm for oncology, metabolism, and the clinical laboratoryClin Chem201763121812182029038145
- WarburgOWindFNegeleinEThe metabolism of tumors in the bodyJ Gen Physiol19278651953019872213
- ZhouZIbekweEChornenkyyYMetabolic alterations in cancer cells and the emerging role of Oncometabolites as drivers of neoplastic changeAntioxidants20187116
- WardPSPatelJWiseDRThe Common Feature of Cancer-Associated IDH1 and IDH2 Mutations is a Neomorphic Enzyme Activity Converting α-ketoglutarate to the Oncometabolite 2-HydroxyglutarateCancer Cell201017322523420171147
- PavlovaNNThompsonCBThe emerging hallmarks of cancer metabolismCell Metab2016231274726771115
- WishartDSMandalRStanislausARamirez-GaonaMCancer metabolomics and the human metabolome databaseMetabolites20166110
- GuptaNKakarAKChowdhuryVGulatiPShankarLRVindalAMagnetic resonance spectroscopy as a diagnostic modality for carcinoma thyroidEur J Radiol200764341441817462842
- MiccoliPTorregrossaLShintuLMetabolomics approach to thyroid nodules: a high-resolution magic-angle spinning nuclear magnetic resonance-based studySurgery201215261118112423158182
- TianYNieXXuSIntegrative metabonomics as potential method for diagnosis of thyroid malignancySci Rep201551486926486570
- RyooIKwonHKimSCMetabolomic analysis of percutaneous fine-needle aspiration specimens of thyroid nodules: Potential application for the preoperative diagnosis of thyroid cancerSci Rep2016613007527440433
- BaeJMA suggestion for quality assessment in systematic reviews of observational studies in nutritional epidemiologyEpidemiol Health201638e201601427156344
- LumbrerasBPortaMMárquezSPollánMParkerLAHernández-AguadoIQUADOMICS: an adaptation of the Quality Assessment of Diagnostic Accuracy Assessment (QUADAS) for the evaluation of the methodological quality of studies on the diagnostic accuracy of “-omics”-based technologiesClin Biochem20084116–171316132518652812
- ZahidMGoldnerWBeselerCLRoganEGCavalieriELUnbalanced estrogen metabolism in thyroid cancerInt J Cancer201313311n/a9
- VillanuevaJNazarianALawlorKYiSSRobbinsRJTempstPA sequence-specific exopeptidase activity test (SSEAT) for “functional” biomarker discoveryMol Cell Proteomics20087350951817986438
- ChenGWangYQiuLHuman IgG Fc-glycosylation profiling reveals associations with age, sex, female sex hormones and thyroid cancerJ Proteomics201275102824283422365975
- CurryJMTassonePCotziaPMulticompartment metabolism in papillary thyroid cancerLaryngoscope2016126102410241826666958
- de GrootJWKemaIPBreukelmanHBiochemical markers in the follow-up of medullary thyroid cancerThyroid200616111163117017123344
- DoSIKimHSKimKPredictive value of sphingosine kinase 1 expression in papillary thyroid carcinomaAnticancer Res201737105399540528982849
- MittalAPoudelBPandeyaDRGuptaSPSathianBYadavSKMetabolic changes enhance the cardiovascular risk with differentiated thyroid carcinoma – a case control study from Manipal Teaching Hospital of NepalAsian Pac J Cancer Prev20121352335233822901217
- RajoriaSSurianoRParmarPS3,3′-diindolylmethane modulates estrogen metabolism in patients with thyroid proliferative disease: a pilot studyThyroid201121329930421254914
- ShangXZhongXTianXMetabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapyTumour Biol2016378111631117526935059
- GuYChenTFuSPerioperative dynamics and significance of amino acid profiles in patients with cancerJ Transl Med20151313525622826
- LeeSHKimKMJungBHChungWYParkCSChungBCEstrogens in female thyroid cancer: alteration of urinary profiles in pre- and post-operative casesCancer Lett20031891273212445674
- IshikawaSTateyaIHayasakaTIncreased expression of phosphatidylcholine (16:0/18:1) and (16:0/18:2) in thyroid papillary cancerPLoS One2012711e4887323139822
- SeoJWHanKLeeJApplication of metabolomics in prediction of lymph node metastasis in papillary thyroid carcinomaPLoS One2018133e019388329509799
- ZhouJLiYChenXZhongLYinYDevelopment of data-independent acquisition workflows for metabolomic analysis on a quadrupoleorbitrap platformTalanta201716412813628107906
- ZhaoWXWangBZhangLYYanSYYangYHAnalysis on the metabolite composition of serum samples from patients with papillary thyroid carcinoma using nuclear magnetic resonanceInt J Clin Exp Med20158101801326770396
- ZhangJFeiderCLNagiCDetection of metastatic breast and thyroid cancer in lymph nodes by desorption electrospray ionization mass spectrometry imagingJ Am Soc Mass Spectrom20172861166117428247296
- YaoZYinPSuDSerum metabolic profiling and features of papillary thyroid carcinoma and nodular goiterMol Biosyst2011792608261421713270
- XuYZhengXQiuYJiaWWangJYinSDistinct metabolomic profiles of papillary thyroid carcinoma and benign thyroid adenomaJ Proteome Res20151483315332126130307
- WojtowiczWZabekADejaSSerum and urine 1H NMR-based metabolomics in the diagnosis of selected thyroid diseasesSci Rep201771910828831094
- ChoiMHMoonJYChoSHChungBCLeeEJMetabolic alteration of urinary steroids in pre- and post-menopausal women, and men with papillary thyroid carcinomaBMC Cancer201111134221824401
- ChenMShenMLiYGC-MS-based metabolomic analysis of human papillary thyroid carcinoma tissueInt J Mol Med20153661607161426459747
- RyooIKwonHKimSCMetabolomic analysis of percutaneous fine-needle aspiration specimens of thyroid nodules: potential application for the preoperative diagnosis of thyroid cancerSci Rep2016613007527440433
- ShenCTZhangYLiuYMA distinct serum metabolic signature of distant metastatic papillary thyroid carcinomaClin Endocrinol2017876844852
- TorregrossaLShintuLNambiath ChandranJToward the reliable diagnosis of indeterminate thyroid lesions: a HRMAS NMR-based metabolomics case of studyJ Proteome Res20121163317332522509853
- GuoLWangCChiCExhaled breath volatile biomarker analysis for thyroid cancerTransl Res2015166218819525666355
- LiuSZhaoGLiJAssociation of polybrominated diphenylethers (PBDEs) and hydroxylated metabolites (OH-PBDEs) serum levels with thyroid function in thyroid cancer patientsEnviron Res20171591828759783
- LuJHuSMiccoliPNon-invasive diagnosis of papillary thyroid microcarcinoma: a NMR-based metabolomics approachOncotarget20167498176827835583
- DejaSDawiskibaTBalcerzakWFollicular adenomas exhibit a unique metabolic profile. 1H NMR studies of thyroid lesionsPLoS One2013812e8463724376829
- HanahanDWeinbergRAThe hallmarks of cancerCell20001001577010647931
- HanahanDWeinbergRAHallmarks of cancer: the next generationCell2011144564667421376230
- WarburgOÜber den Stoffwechsel der CarcinomzelleNaturwissenschaften1924125011311137
- WarburgOOn the origin of cancer cellsScience1956123319130931413298683
- VolkTJähdeEFortmeyerHPGlüsenkampKHRajewskyMFpH in human tumour xenografts: effect of intravenous administration of glucoseBr J Cancer19936834925008353039
- Delli CastelliDFerrautoGCutrinJCTerrenoEAimeSIn vivo maps of extracellular pH in murine melanoma by CEST-MRIMagn Reson Med201471132633223529973
- FadakaAAjiboyeBOjoOAdewaleOOlayideIEmuowhochereRBiology of glucose metabolization in cancer cellsJ Oncol Sci2017324551
- HamanakaRBChandelNSTargeting glucose metabolism for cancer therapyJ Exp Med2012209221121522330683
- LeeASGlucose-regulated proteins in cancer: molecular mechanisms and therapeutic potentialNat Rev Cancer201414426327624658275
- WolfAAgnihotriSMicallefJHexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiformeJ Exp Med2011208231332621242296
- ShenC-TZhangYLiuY-MA distinct serum metabolic signature of distant metastatic papillary thyroid carcinomaClin Endocrinol2017876844852
- GuYChenTFuSPerioperative dynamics and significance of amino acid profiles in patients with cancerJ Transl Med20151313525622826
- ZhaoWXWangBZhangLYYanSYYangYHAnalysis on the metabolite composition of serum samples from patients with papillary thyroid carcinoma using nuclear magnetic resonanceInt J Clin Exp Med2015810180131802226770396
- WojtowiczWZabekADejaSSerum and urine 1H NMR-based metabolomics in the diagnosis of selected thyroid diseasesSci Rep201771910828831094
- MiyoshiEItoYMiyoshiYInvolvement of aberrant glycosylation in thyroid cancerJ Oncol20102010217
- PlompRRuhaakLRUhHWSubclass-specific IgG glycosylation is associated with markers of inflammation and metabolic healthSci Rep2017711232528951559
- ZhangDChenBWangYDisease-specific IgG Fc N-glycosylation as personalized biomarkers to differentiate gastric cancer from benign gastric diseasesSci Rep2016612595727173519
- PinhoSSReisCAGlycosylation in cancer: mechanisms and clinical implicationsNat Rev Cancer201515954055526289314
- ZąbczyńskaMKozłowskaKPochećEGlycosylation in the thyroid gland: vital aspects of glycoprotein function in thyrocyte physiology and thyroid disordersInt J Mol Sci20181992792
- BrizelDMSchroederTScherRLElevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancerInt J Radiat Oncol Biol Phys200151234935311567808
- WalentaSSchroederTMueller-KlieserWLactate in solid malignant tumors: potential basis of a metabolic classification in clinical oncologyCurr Med Chem200411162195220415279558
- KoppenolWHBoundsPLDangCVOtto Warburg’s contributions to current concepts of cancer metabolismNat Rev Cancer201111532533721508971
- RogatzkiMJFergusonBSGoodwinMLGladdenLBLactate is always the end product of glycolysisFront Neurosci201594082225774123
- MichielsCPhysiological and pathological responses to hypoxiaAm J Pathol200416461875188215161623
- San-MillánIBrooksGAReexamining cancer metabolism: lactate production for carcinogenesis could be the purpose and explanation of the Warburg EffectCarcinogenesis201738211913327993896
- Romero-GarciaSMoreno-AltamiranoMMPrado-GarciaHSánchez-GarcíaFJLactate contribution to the tumor microenvironment: mechanisms, effects on immune cells and therapeutic relevanceFront Immunol20167Pt 25226909082
- JiangBAerobic glycolysis and high level of lactate in cancer metabolism and microenvironmentGenes Dis201741252730258905
- RidgwayNDThe role of phosphatidylcholine and choline metabolites to cell proliferation and survivalCrit Rev Biochem Mol Biol2013481203823350810
- LiYChenMLiuCMetabolic changes associated with papillary thyroid carcinoma: a nuclear magnetic resonance-based metabolomics studyInt J Mol Med20184153006301429484373
- KwonHOhSJinXAnYJParkSCancer metabolomics in basic science perspectiveArch Pharm Res201538337238025630795
- JainMNilssonRSharmaSMetabolite profiling identifies a key role for glycine in rapid cancer cell proliferationScience201233660841040104422628656
- ZhangWCShyh-ChangNYangHGlycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesisCell20121481–225927222225612
- MycielskaMEDettmerKRümmelePExtracellular citrate affects critical elements of cancer cell metabolism and supports cancer development In VivoCancer Res201878102513252329510993
- HatzivassiliouGZhaoFBauerDEATP citrate lyase inhibition can suppress tumor cell growthCancer Cell20058431132116226706
- ZaidiNSwinnenJVSmansKATP-citrate lyase: a key player in cancer metabolismCancer Res201272153709371422787121
- RenJGSethPYeHCitrate suppresses tumor growth in multiple models through inhibition of glycolysis, the tricarboxylic acid cycle and the IGF-1R pathwaySci Rep201771453728674429
- DangLYenKAttarECIDH mutations in cancer and progress toward development of targeted therapeuticsAnn Oncol201627459960827005468
- YeDGuanKLXiongYMetabolism, activity, and targeting of D- and L-2-hydroxyglutaratesTrends Cancer20184215116529458964
- WardPSCrossJRLuCIdentification of additional IDH mutations associated with oncometabolite R(-)-2-hydroxyglutarate productionOncogene201231192491249821996744
- ChoiCGanjiSKDeberardinisRJ2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomasNat Med201218462462922281806
- GrossSCairnsRAMindenMDCancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutationsJ Exp Med2010207233934420142433
- ShimEHLiviCBRakhejaDL-2-Hydroxyglutarate: an epi-genetic modifier and putative oncometabolite in renal cancerCancer Discov20144111290129825182153
- RakhejaDBoriackRLMituiMKhokharSHoltSAKapurPPapillary thyroid carcinoma shows elevated levels of 2-hydroxyglutarateTumour Biol201132232533321080253
- HemerlyJPBastosAUCeruttiJMIdentification of several novel non-p.R132 IDH1 variants in thyroid carcinomasEur J Endocrinol2010163574775520702649
- WardPSLuCCrossJRThe potential for isocitrate dehydrogenase mutations to produce 2-hydroxyglutarate depends on allele specificity and subcellular compartmentalizationJ Biol Chem20132886jbc. M112:38043815
- AlimoghaddamKShariftabriziATavangarSMAnti-leukemic and anti-angiogenesis efficacy of arsenic trioxide in new cases of acute promyelocytic leukemiaLeuk Lymphoma2006471818816321832
- MillerVMEstrogen metabolomics: a physiologist’s perspectiveHypertension201056581681820921431
- AlakwaaFMChaudharyKGarmireLXDeep learning accurately predicts estrogen receptor status in breast cancer metabolomics dataJ Proteome Res201817133734729110491
- TongXZhaoFThompsonCBThe molecular determinants of de novo nucleotide biosynthesis in cancer cellsCurr Opin Genet Dev2009191323719201187
- MannavaSGrachtchoukVWheelerLJDirect role of nucleotide metabolism in C-MYC-dependent proliferation of melanoma cellsCell Cycle20087152392240018677108
- CoryJGCoryAHCritical roles of glutamine as nitrogen donors in purine and pyrimidine nucleotide synthesis: asparaginase treatment in childhood acute lymphoblastic leukemiaIn Vivo200620558758917091764
- CantorJRSabatiniDMCancer cell metabolism: one hallmark, many facesCancer Discov201221088189823009760
- WiseDRThompsonCBGlutamine addiction: a new therapeutic target in cancerTrends Biochem Sci201035842743320570523
- KhatamiFLarijaniBHeshmatRKeshtkarAMohammadamoliMTeimoori-ToolabiLNasiriSTavangarSM2017Meta-analysis of promoter methylation in eight tumor-suppressor genes and its association with the risk of thyroid cancerPlos One129e018489228926589
- NatanziMMPasalarPKamalinejadMDehpourARTavangarSMSharifiRGhanadianNRahimi-BalaeiMGerayesh-NejadS2012Effect of aqueous extract of Elaeagnus angustifolia fruit on experimental cutaneous wound healing in ratsActa Medica Iranica50958959623165807
- OmidfarKMoinfarZSohiANTavangarSMHaghpanahVHeshmatRKashanianSLarijaniBExpression of EGFRvIII in thyroid carcinoma: immunohistochemical study by camel antibodiesImmunological Investigations2009113821658019330625